Azacitidin Accord 100 mg, Pulver zur Herstellung einer Injektionssuspension

7680667700012 CH-66770 Pulver zur Herstellung einer Injektionssuspension
Azacitidin Accord 100 mg, Pulver zur Herstellung einer Injektionssuspension
Azacitidin Accord 100 mg, Pulver zur Herstellung einer Injektionssuspension
Azacitidin Accord 100 mg, Pulver zur Herstellung einer Injektionssuspension
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver zur Herstellung einer Injektionssuspension
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/11/2024
Summary of Product Characteristics
Français
08/11/2024
Summary of Product Characteristics
Italien
08/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 259.95
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/02/2019

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
66770
Drug name
Azacitidin Accord, Pulver zur Herstellung einer Injektionssuspension
Galenic form
PULPA
ATC Code
L01BC07
Authorization status
Z
Dispensing category
A
First authorization
28/11/2018
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
AZACITIDIN Accord subst sèche 100 mg flac
Description (DE)
AZACITIDIN Accord Trockensub 100 mg Durchstf
Market launch
28/11/2018
Narcotic (BTM)
No

Original drug

Vidaza, Lyophilisat zur Herstellung einer Injektionssuspension
GTIN: 7680573800011
CHF 350.75
View original

Other package sizes (1)

None
1 DUR
GTIN: None
Not in V1